Highlights this week – a 10-year AAV gene therapy study, scaling up manufacturing, pharma advertising trends, and a hugely important topic: access to medicine. Access to vaccines is a hot topic as COVID-19 immunization programs begin to roll out. But vaccines aren’t the only therapeutics with access challenges; even common generic medicines are experiencing stretched supply chains. Warwick Smith, Director General of the British Manufacturing Generics Association, discusses the issues.

 

Stephanie Sutton, Editor
 
ADVANCED MEDICINE
The Scale-Up Mindset
12/30/2020 | James Strachan
Key opinion leaders share their views on the importance of ATMP scale up.
ADVANCED MEDICINE
The More You Know…
01/02/2021 | James Strachan
A decade-long AAV gene therapy study in dogs emphasizes the importance of long-term follow up.
BUSINESS PRACTICE
Advocate for Access
01/14/2021 | Maryam Mahdi
We sit down with the British Generics Manufacturers Association's Warwick Smith.
BUSINESS PRACTICE
The Advertising Push
01/11/2021 | Maryam Mahdi
What factors are driving pharma's move towards digital marketing?
 
Webinars
New Webinar: What are the side effects of bad data in API development and manufacture?

Innovation is key to delivering new drugs faster and cheaper, while tailoring them to patient needs. Data drives this, but how do you know it’s the right data? We would like to invite you to a new webinar with Malvern Panalytical, where we will delve into the side effects of bad data in API development and manufacture. Find out more.
Smart Shipping Solutions For Cell Therapy Logistics

Our webinar with Cytiva on overcoming cell therapy logistics without the hazards of liquid nitrogen is now available to view on demand. Stream now
 
White Papers
Technology for combating counterfeit medicine

This white paper examines the issue of counterfeit drugs, reviewing the various types produced and the nature and range of the damage they cause. The report then focuses on analytical methods for tackling the problem, in particular the use of X-ray powder diffraction (XRPD). Read more
Protein stability analysis technologies for the biopharmaceutical industry

This buyer's guide discusses the available instrumentation for protein stability characterization, and what to consider when choosing stability assays. Protein stability and higher order structure is used to assist with biocomparability studies. Read more
 
Product Profiles
Quali-G™ Liquid, the definitive liquid encapsulation solution

Qualicaps® continues to innovate by presenting a liquid encapsulation solution that aids in overcoming typical issues found in the complex filling operation of low viscosity liquids into hard capsules. Read more
The first ever human trial of a nanoformed drug

Nanoform has partnered with Quotient Sciences to start the first ever human trial of a drug candidate nanoformed using its CESS® technology, opening up exciting possibilities for the future of medicine. Read more
 
Special Promotions
Seamless Scalability – 50 L and Beyond

Designed to save time and to mitigate risks. Discover the BioFlo 720, the newest pilot and production scale bioprocess controller from Eppendorf and experience reliable tech transfer from 0.3 L - 2.000 L. Learn more
Learning from the Pandemic

Dominique Henry from Terumo believes highlights the importance of a unified global network and Shawn Walker from Johnson Matthey discusses pharma’s “smaller, safer – but more complex” – future. Learn more
Help us measure “Pandemic Impact” in Biopharma for a chance to win $100!

Take the “Pandemic Impact: Biopharma Trends 2021 Survey” now and you could win a $100 Amazon voucher (or a charitable donation, if preferred). Start Survey
6th CAR-TCR Summit Europe

The 6th CAR-TCR Summit Europe is Dedicated to Accelerating the Development of Novel CAR & TCR Technologies, to Deliver Safe, Efficacious & Affordable Advanced Therapies. View our 55+ speaker agenda!
 
Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.
Find out more
This email was sent to {~email~} by info@themedicinemaker.com. To ensure delivery of emails to your inbox, please add info@themedicinemaker.com to your address book or safe sender list. To view online, please click here.

Create or manage your account here
Unsubscribe here

The Medicine Maker is a brand of Texere Publishing Limited

Texere Publishing Limited, Booths Park 1,
Chelford Road, Knutsford, WA16 8GS, UK
Registered Company Number: 08113419
Texere Publishing Inc., 115 Broadway, FL 5,
New York, NY 10006, USA
Federal Identification Number: 81-4613586